Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

SINOMED® Completes One-Year Follow-Up of the PIONEER-III European, US and Japanese Trial of the BuMA Supreme® Coronary Drug-Eluting Stent

prnasiaJuly 13, 2020

Tag: SINOMED , PIONEER-III European , Drug-Eluting Stent

PharmaSources Customer Service